Comparing Two Nerve Blocks for Pain Relief After Lung Cancer Keyhole Surgery
Compares two nerve blocks for pain after lung cancer surgery in adults.
Key facts
- Who runs it
- Nanjing First Hospital, Nanjing Medical University
- Where
- Nanjing, ChinaSee the site
- Trial code
- Registry title
- Analgesic Effects of Retro-superior Costotransverse Ligament Space Block for Video-assisted Thoracoscopic Surgery
- Status
- Recruiting
- People taking part
- 130 people, planned
- Started
- 5 Aug 2026
- Expected to end
- 30 May 2028
- Type of study
- Interventional, 2 groups
- Treatments tested
- Ultrasound-guided retro-SCTLB
- Ultrasound-guided TPVB
- Record updated
- 6 August 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults having keyhole (thoracoscopic) surgery to remove lung cancer under general anesthesia. It compares two pain-relief nerve blocks after surgery.
- Age
- 18 to 80 years
- Sex
- All sexes
- Disease stage
- Planned thoracoscopic radical surgery for lung cancer under general anesthesia. ASA class I-III.
- Earlier treatment
- No history of opioid abuse.
Main reasons for not taking part
- Allergy to the study drug or local anesthetic
- History of opioid abuse
- Skin infection at the needle site of ITPN or TPVB
- Peripheral infectious neuropathy
- Blood clotting disorder
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Patients scheduled for thoracoscopic radical lung cancer surgery under general anesthesia；
- aged 18-80 years；
- BMI 18-30 kg/m²；
- ASA classification I-III；
Who cannot take part
- Allergy to the study drug or local anesthetic
- History of opioid abuse
- Pre-existing skin infection at the puncture site of ITPN or TPVB
- Peripheral infectious neuropathy
- Dysfunction of blood coagulation
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Where in China
- Nanjing First HospitalNanjing, ChinaContact: Tao ShanTaking people
About the trial
What the trial wants to find out
The aim of this clinical trial is to investigate the effects of postoperative analgesia during retro-SCTLB(retro superior costotransverse ligament space block) and TPVB(thoracic paravertebral block) in patients undergoing thoracoscopic radical resection of lung cancer。By comparing the dosage of opioid drugs after surgery, the impact of retro-SCTLB and TPVB on the postoperative analgesic effect was evaluated.
The 2 groups in the trial
- retro-SCTLB groupTreatment being tested
A total of 20 ml of the 0.375% ropivacaine is injected in the retro-superior costotransverse ligament space in the retro-SCTLB group。
Treatment: Ultrasound-guided retro-SCTLB
- TPVB groupTreatment being tested
A total of 20 ml of the 0.375% ropivacaine is injected in the paravertebral space in the TPVB group .
Treatment: Ultrasound-guided TPVB
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Postoperative Analgesic Effects of Ultrasound-guided Retro-superior Costotransverse Ligament Space Block After Video-assisted Thoracoscopic Surgery: a Prospective Randomized Controlled Trial
- Plain-language title
- Comparing Two Nerve Blocks for Pain Relief After Lung Cancer Keyhole SurgeryGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 13 November 2026.
- Fit questions
- Built from NCT07745881, who can take part
- Record updated
- 6 August 2026